Study of mechanisms of calcitonin analgesia in miceInvolvement of 5-HT3 receptors

Brain Research

Volumn 845, Issue 2, 1999, Pages 130-138

  Ormazábal, Ma Jesús ^a   Goicoechea, Carlos ^a   Alfaro, Ma José ^a   Sánchez, Eva ^a   Martín, Ma Isabel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

5 HT receptor; Analgesia; Calcitonin; Mice; Serotonin; Writhing test

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2 METHYLSEROTONIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 HYDROXYTRYPTOPHAN; CALCITONIN; KETANSERIN; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; SEROTONIN; SEROTONIN 3 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; TROPISETRON;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; WRITHING TEST;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANALGESICS; ANIMALS; BRAIN CHEMISTRY; CALCITONIN; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLES; INDOPHENOL; KETANSERIN; MALE; MICE; MICE, INBRED STRAINS; NOCICEPTORS; PAIN; PAIN MEASUREMENT; PIPERAZINES; PYRIDINES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0345493915     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01839-9     Document Type: Article

References (34)

1. 2 receptors in nociceptive transmission. Brain Res. 543:1991;335-340.
2. Bijvoet O.L.M., Hjansen A.P. Thyrocalcotinin in Paget's disease. Lancet. 2:1967;471-472.
3. 3H ]5-hydroxytryptamine release from the rat spinal cord Eur. J. Pharmacol. 156:1988;13-23.
4. 1A receptors in social conflict induced analgesia in mice. Eur. J. Pharmacol. 345:1998;253-256.
5. 1A receptor agonist, impairs performance in a passive avoidance task. Eur. J. Pharmacol. 211:1992;227-234.
6. F. Cesselin, A.M. Laporte, M.C. Miquel, S. Bourgoin, M. Hamon, Serotonergic mechanisms of pain control, in: G.F. Gebhart, D.L. Hammond, T.S. Jensen (Eds.), Proceedings of the 7th World Congress on Pain. Progress in pain research and management, IASP Press, Seattle, 1994, pp. 669-689.
7. Cheng C.H.K., Costall B., Kelly M.E., Naylor R.J. Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behavior in the light/dark test. Eur. J. Pharmacol. 255:1994;39-49.
8. Clementi G., Amico-Roxas M., Rasiparda E., Caruso A., Prato A., Trombadore S., Priolo G., Scapagnini U. The analgesic activity of calcitonin and the central serotonergic system. Eur. J. Pharmacol. 108:1985;71-75.
9. Clementi G., Prato A., Conforto G., Scapagnini U. Role of serotonin in the analgesic activity of calcitonin. Eur. J. Pharmacol. 94:1984;449-451.
10. Colado M.I., Ormazábal M.J., Goicoechea C., López F., Alfaro M.J., Martín M.I. Involvement of central serotonergic pathways in analgesia elicited by salmon calcitonin in the mouse. Eur. J. Pharmacol. 252:1994;291-297.
11. 3 receptors. Brain Res. 788:1998;20-24.
12. 1A receptor antagonists: utility as research tools and therapeutic agents. TIPS. 14:1993;441-448.
13. Forster E.A., Cliffe I.A., Bill D.J., Dover G.M., Jones D., Reilly Y., Fletcher A. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 281:1995;81-88.
14. Gennari C., Agnusdei D. Calcitonin in bone pain management. Curr. Ther. Res. 44:1988;712-722.
15. Giordano J. Analgesic profile of centrally administered 2-methylserotonin against acute pain in rats. Eur. J. Pharmacol. 199:1991;233-236.
16. Green A.R., De Souza R.J., Williams J.L., Murray T.K., Cross A.J. The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole. Neuropharmacology. 31:1992;315-321.
17. Greenshaw A.J. Behavioral pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential. Trends Neurosci. 14:1993;313-317.
18. Hayashi G., Takemori A.E. The type of analgesic-receptor interaction involved in certain analgesic assays. Eur. J. Pharmacol. 16:1971;63-66.
19. 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;463-471.
20. Hunskaar S., Berge O.G., Broch O.J., Hole K. Lesion of the ascending serotonergic pathways and antinociceptive effects after systemic administration of p-chloroamphetamine in mice. Pharmacol. Biochem. Behav. 24:1986;709-714.
21. Hunskaar S., Fasmer O.B., Broch O.J., Hole K. Involvement of central serotonergic pathways in nefopam-induced antinociception. Eur. J. Pharmacol. 138:1987;77-82.
22. Kessel C., Worz R. Immediate response to phantom limb pain to calcitonin. Pain. 30:1987;79-87.
23. Kiefel J.M., Cooper M.L., Bodnar R.J. Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia. Brain Res. 597:1992;331-338.
24. Martín M.I., Goicoechea C., Ormazábal M.J., Alfaro M.J. Influence of pertussis toxin on the calcitonin-opioid interaction in isolated tissues. Br. J. Pharmacol. 119:1996;804-806.
25. Meller S.T., Lewis S.J., Brody M.J., Gebhart G.F. Vagal afferent-mediated inhibition of a nociceptive reflex by iv serotonin in the rat: II. Role of 5-HT receptor subtypes. Brain Res. 585:1992;71-86.
26. 1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice. Pain. 58:1994;45-61.
27. 3 receptor antagonists on the writhing response in mice. Gen. Pharmacol. 26:1995;1301-1306.
28. Nikfar S., Abdollahi M., Kebriaeezadeh A., Chitsaz M. Effect of granisetron on morphine-induced analgesia in mice by formalin test. Gen. Pharmacol. 31:1998;55-58.
29. Ormazábal M.J., Milanés M.V., Martín M.I. Serotonergic mechanisms involved in calcitonin potentiation of κ-opioid receptor-mediated effects on adrenal secretion. Eur. J. Pharmacol. 340:1997;81-87.
30. 1A receptor agonists on 5-HT release in rat brain in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 348:1993;339-346.
31. Taiwo Y.O., Levine J.D. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience. 48:1992;485-490.
32. Talley N.J. Review article: 5-hydroxitryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment. Pharmacol. Ther. 6:1992;273-289.
33. 3 receptor mRNA. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1430-1434.
34. Welch S.P., Cooper C.W., Dewey W.L. Antinociceptive activity of salmon calcitonin injected intraventricularly in mice: modulation of morphine antinociception. J. Pharmacol. Exp. Ther. 237:1986;54-58.